CPHI & PMEC India Expo: Encouraging affordable solutions in India’s march towards a $130 Billion Pharma Market by 2030

• 17^th edition of CPHI& PMEC India Expo to be held from 26^th November-28^thNovember 2024, at the India Expo Centre, Greater Noida, Delhi-NCR
• The Expo will bring together over 50000 visitors and 2000 exhibitors providing a unique environment for industry experts to share ideas and drive their business forward
• The Expo to showcase 10,000+ products, offering a unique space for collaboration and innovation in Pharma
• Dedicated sessions on industry advancements, digital transformation, agile manufacturing, and women in pharma

New Delhi, November 13, 2024: As a significant milestone in India’s pharma sector, the 17th edition of CPHI & PMEC India, organised by Informa Markets in India, returns in an advanced format, scheduled from 26th to 28th November 2024 at the India Expo Centre, Greater Noida, Delhi-NCR. Renowned as a comprehensive, one-stop destination for  innovative, cost-effective solutions, the expo will be showcasing the pharmaceutical industry’s modernization, innovation, and sustainability.

India’s pharma industry is on an impressive growth trajectory, expected to reach $65 billion by 2024 and to double to $130 billion by 2030. CPHI & P-MEC India exemplifies this growth by connecting global and domestic stakeholders to showcase advancements in pharmaceutical machinery, technology, and ingredients. This year, the expo offers a pivotal marketplace for over 2000 exhibitors to engage, with anticipated participation from countries including the USA, UAE, South Korea, Japan, Egypt, Vietnam, the Philippines, Malaysia, Italy, Sri Lanka, Bangladesh, Nepal, Iran, and the United Kingdom. 

A Marketplace for Innovation and Growth

With a comprehensive array of exhibitors, CPHI & PMEC India enables direct engagement with pharmaceutical executives, buyers, hospital administrators, and government representatives. Noteworthy exhibitors include Dr. Reddy’s Laboratories Ltd, Biocon Ltd, 

Glenmark Lifesciences Ltd, Morepen Laboratories Ltd, Hetero Labs Limited, Lupin Ltd, Signet Excipients Pvt. Ltd, Apitoria Pharma Pvt Ltd, Capsugel Healthcare Pvt. Ltd, Supriya Lifescience Ltd, SMS Pharmaceuticals Ltd, MSN Laboratories Pvt. Ltd, Sekhmet Pharmaventures Pvt. Ltd, Tirupati Lifesciences Pvt. Ltd,  Merck Life Science Pvt. Ltd. and many others. Among PMEC exhibitors are ACG, Accupack Engineering, Ace Technologies, Avish Machines, Bowman & Archer Pharma Machines, Cadmach Machinery, CAM PAK India, Fette India, IMA Industria Macchine, Parle Global Technologies, Snowbell Machines, and Truking Technology, showcasing cutting-edge equipment for pharmaceutical manufacturing. 

Industry Collaboration and Support

This year, the expo continues to enjoy substantial support from key industry associations such as CIPI, FOPE (Federation of Pharma Entrepreneurs), IPEC India, and Pharmexcil, solidifying its reputation as the industry’s most promising show.

Highlighting the significance of this year’s CPHI & PMEC India Expo, Mr. Yogesh Mudras, Managing Director, Informa Markets in India, said, “India’s pharmaceutical industry, currently ranked third globally by production volume, has evolved into a thriving sector with a CAGR of 9.43% over the past nine years. Known for delivering high-quality, affordable medicines, India has earned its reputation as the ‘Pharmacy of the World.’ The Ministry’s ‘Strengthening of Pharmaceutical Industry (SPI)’ initiative, backed by Rs. 500 crore (USD 60.9 million) provides vital support to enhance productivity, quality, and sustainability across pharma clusters and MSMEs nationwide. Over the last 16 years, CPHI & P-MEC India Expo has mirrored the industry’s vision and growth. Now, as a key part of the world’s largest global pharmaceutical community, it has transformed from a trade show into a robust platform for expanding business opportunities and delivering real-time industry insights, positioning us at the forefront of global pharmaceutical advancements.”

Event focused on Industry Evolution

The CPHI & PMEC India Expo includes The Pharma Connect Congress, a two days gathering, focusing on critical discussions including ‘Continuous Innovation & Agile Manufacturing for the Next Generation Therapeutics’; ‘India as the “Pharmacy of the World” with Cost Effective Generics and Biosimilars’; ‘The Digital Transformation Panel: Addressing the Challenges in Adopting Digital Technologies’; ‘Advance your Research Decisions on Biosimilars with Confidence’; ‘Navigating the Complexity of Biosimilar Manufacturing’; ‘High Performance Fluoropolymers for Increased Productivity, Improved Quality and Enhanced Safety in Pharmaceuticals & Allied Industry’, among other relevant topics. The Pharma Leaders Roundtable is a closed-door forum for senior industry leaders to discuss strategic pathways for innovation, unmet clinical needs, and future-ready solutions. The Women in Pharma Conference programme focuses on uplifting female professionals and enhancing diversity within the Indian pharma industry. This year, the 10th edition of the India Pharma Awards recognizing exceptional contributions to the industry, the awards celebrate excellence across pharma brands.

As India’s premier event for the pharmaceutical sector, CPHI & PMEC India Expo reinforces its commitment to advancing the pharma industry, supporting innovation, and establishing India’s role on the global pharmaceutical stage.

Corporate Comm India (CCI Newswire)